P3 Health Partners Inc. (NASDAQ:PIII - Get Free Report) shares hit a new 52-week low during trading on Tuesday . The company traded as low as $7.00 and last traded at $8.99, with a volume of 81115 shares traded. The stock had previously closed at $7.58.
P3 Health Partners Price Performance
The company has a debt-to-equity ratio of 1.11, a current ratio of 0.53 and a quick ratio of 0.53. The company has a market cap of $66.36 million, a PE ratio of -11.00 and a beta of 0.96. The company has a 50-day moving average price of $9.31 and a two-hundred day moving average price of $11.81.
P3 Health Partners (NASDAQ:PIII - Get Free Report) last released its quarterly earnings results on Thursday, March 27th. The company reported ($16.00) earnings per share for the quarter, missing analysts' consensus estimates of ($8.50) by ($7.50). The company had revenue of $370.69 million during the quarter, compared to analysts' expectations of $378.88 million. P3 Health Partners had a negative return on equity of 71.31% and a negative net margin of 6.95%. Sell-side analysts expect that P3 Health Partners Inc. will post -0.67 earnings per share for the current fiscal year.
Institutional Investors Weigh In On P3 Health Partners
Several hedge funds and other institutional investors have recently added to or reduced their stakes in PIII. Geode Capital Management LLC grew its stake in shares of P3 Health Partners by 115.2% during the third quarter. Geode Capital Management LLC now owns 1,029,259 shares of the company's stock valued at $398,000 after acquiring an additional 550,925 shares in the last quarter. Trinity Financial Advisors LLC bought a new position in shares of P3 Health Partners during the fourth quarter worth about $261,000. Sanders Morris Harris LLC lifted its holdings in P3 Health Partners by 50.0% during the 4th quarter. Sanders Morris Harris LLC now owns 184,497 shares of the company's stock worth $41,000 after buying an additional 61,499 shares during the last quarter. Wealthedge Investment Advisors LLC bought a new stake in shares of P3 Health Partners in the 4th quarter valued at approximately $83,000. Finally, XTX Topco Ltd acquired a new stake in shares of P3 Health Partners during the 4th quarter valued at approximately $46,000. Hedge funds and other institutional investors own 7.75% of the company's stock.
P3 Health Partners Company Profile
(
Get Free Report)
P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.
Featured Articles
Before you consider P3 Health Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and P3 Health Partners wasn't on the list.
While P3 Health Partners currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
